Figures
Abstract
Lung branching morphogenesis requires reciprocal interactions between the epithelium and mesenchyme. How the lung branches are generated at a defined location and projected toward a specific direction remains a major unresolved issue. In this study, we investigated the function of Wnt signaling in lung branching in mice. We discovered that Wnt5a in both the epithelium and the mesenchyme plays an essential role in controlling the position and direction of lung branching. The Wnt5a signal is mediated by Vangl1/2 to trigger a cascade of noncanonical or planar cell polarity (PCP) signaling. In response to noncanonical Wnt signaling, lung cells undergo cytoskeletal reorganization and change focal adhesions. Perturbed focal adhesions in lung explants are associated with defective branching. Moreover, we observed changes in the shape and orientation of the epithelial sheet and the underlying mesenchymal layer in regions of defective branching in the mutant lungs. Thus, PCP signaling helps define the position and orientation of the lung branches. We propose that mechanical force induced by noncanonical Wnt signaling mediates a coordinated alteration in the shape and orientation of a group of epithelial and mesenchymal cells. These results provide a new framework for understanding the molecular mechanisms by which a stereotypic branching pattern is generated.
Citation: Zhang K, Yao E, Chuang E, Chen B, Chuang EY, Volk RF, et al. (2022) Wnt5a–Vangl1/2 signaling regulates the position and direction of lung branching through the cytoskeleton and focal adhesions. PLoS Biol 20(8): e3001759. https://doi.org/10.1371/journal.pbio.3001759
Academic Editor: Emma Rawlins, University of Cambridge, UNITED KINGDOM
Received: January 14, 2022; Accepted: July 18, 2022; Published: August 26, 2022
Copyright: © 2022 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Gene Expression Omnibus database accessible through GEO Series accession number (GSE188993). UCSD Mass Spectrometry Interactive Virtual Environment (MassIVE) number MSV000089851.
Funding: PTC was supported by National Institutes of Health R01 HL142876 (National Heart, Lung, and Blood Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: cRAP, common repository of adventitious proteins; dpc, days post coitus; ECM, extracellular matrix; FAK, focal adhesion kinase; FDR, false discovery rate; FZ, Frizzled; GO, gene ontology; p-Cofilin, phosphorylated Cofilin; PCP, planar cell polarity; PEI, polyethylenimine; PFA, paraformaldehyde; p-FAK, phosphorylated FAK; pMLC, phosphorylated myosin light chain; RAc, right accessory; RCd, right caudal; RCr, right cranial; RMd, right middle
Introduction
Branching morphogenesis is a fundamental mechanism for pattern formation [1,2]. It is utilized by many organs and vasculature to generate a defined pattern required for tissue function. The lung, kidney, mammary gland, salivary gland, pancreas, and prostate are among the branching organs that have been extensively studied. For instance, many genes and pathways that control lung branching have been discovered [3–5]. However, we still lack a complete mechanistic understanding of how new lung branches are formed and extended in a spatially and temporally specific manner. In particular, the cellular and molecular basis of how lung epithelial cells undergo morphogenetic changes to produce a new branch remains underexplored [6,7].
The planar cell polarity (PCP) pathway is an evolutionarily conserved mechanism for orchestrating cell shape and motility during pattern formation [8–11]. PCP signaling has been broadly investigated. The major components of the PCP pathway are known, and their genetic interactions have been defined. The PCP pathway is the noncanonical branch of the Wnt pathway. Similar to the canonical Wnt pathway, PCP signaling is triggered by binding of the Wnt ligands to their cell surface receptors that include the Frizzled (FZ) receptors and ROR coreceptors. However, instead of controlling β-catenin levels as seen in the canonical Wnt pathway, PCP signaling utilizes multiple transmembrane and cytoplasmic proteins to regulate the actomyosin cytoskeleton. How changes in cellular properties induced by PCP signaling influence branching morphogenesis is a key unresolved question. Insight into this issue will offer a new framework for understanding branching morphogenesis.
Among the several Wnts that are expressed in the lung, Wnt5a is a prominent member of the noncanonical Wnt family [12]. Wnt5a is also capable of mediating canonical Wnt signaling [13,14]. The role of Wnt5a in lung branching has not been fully explored. A previous report on Wnt5a−/− mouse lungs primarily focused on later stages (e.g., 16.5 to 18.5 days post coitus (dpc)) of lung development and concluded that Wnt5a controls distal lung morphogenesis [15]. Whether Wnt5a regulates early lung branching is unknown and the sources of Wnt5a in this process were not functionally defined.
Similarly, how the downstream effectors of Wnt5a control lung branching is unclear. In the literature, a hypomorphic (reduced function) allele of Vangl2, Vangl2Lp (loop tail) [16], has been widely used. Vangl1 and Vangl2 encode the mammalian homologs of fly Van Gogh (Vang)/strabismus and are absolutely required for PCP signaling [17]. Homozygous Vangl2Lp/Lp mice die in utero due to an open neural tube. Analysis of Vangl2Lp/Lp lungs revealed defective branching, resulting in fewer branches and narrow lumens [18]. Disrupted cytoskeletal organization was also observed in Vangl2Lp/Lp lungs [18]. However, intact Vangl1 and residual Vangl2 activity in Vangl2Lp/Lp mutants retained PCP signaling and prevented an accurate assessment of how PCP signaling promotes lung branching, especially during the early steps of branch formation. A complete loss of both Vangl1 and Vangl2 function is required to uncover the molecular mechanisms by which PCP signaling regulates branching. In addition, loss of PCP signaling in a select compartment (e.g., the lung epithelium or mesenchyme) through conditional gene inactivation is necessary to investigate PCP signaling in different niches.
In this study, we have defined the role of epithelial and mesenchymal Wnt5a in controlling the position and direction of lung branching. A complete loss of Vangl1/2, the effectors of Wnt5a, resulted in similar albeit milder phenotypes than those due to Wnt5a removal. We discovered that cytoskeletal reorganization induced by PCP signaling leads to changes in focal adhesions required for branching. This is associated with alterations in the shape and orientation of the epithelial sheet and the underlying mesenchymal layer in regions of defective branching in the mutant lungs. Together, these novel findings reveal a molecular cascade that controls cellular properties required for branching morphogenesis.
Results
Global inactivation of Wnt5a perturbs the position and direction of early lung branching
To search for signals that trigger PCP signaling and lung branching, we tested the function of Wnt5a and examined branching in lungs of Wnt5a−/− mice especially at the early stages of lung development. The null allele of Wnt5a (Wnt5a−) was derived from the floxed allele of Wnt5a (Wnt5af) [19] by Sox2-Cre [20]. We found that defective lung branching was already apparent in Wnt5a−/− lungs at 11.5 dpc (Fig 1A–1C). The most striking feature of Wnt5a−/− lungs was the loss of proper position and orientation of the lung buds when the initial pattern was being generated. As lung development proceeded, the well-established programs that are dubbed domain branching and planar and orthogonal bifurcation were also impaired. The phenotype was completely penetrant.
(A-I) Ventral (A, B, D, E, G, H) and dorsal (C, F, I) views of dissected lungs from control and Wnt5a−/− mouse embryos at the developmental stages indicated. E-Cad marked epithelial cells. (J) Quantification of the ratio of the distance of RMd–RCr to the distance of RMd–bifurcation (mean value ± SEM, unpaired Student’s t-test, n = 17 pairs). (K) Quantification of the angle (in degrees) between RMd and RCd branches (mean value ± SEM, unpaired Student’s t-test, n = 17 pairs). (L) Quantification of the angle (in degrees) between RAc and RCd branches (mean value ± SEM, unpaired Student’s t-test, n = 17 pairs). (M-R) Immunostaining of lung sections collected from control and Wnt5a−/− at 12.5 dpc. (S) Schematic diagram of the position and direction of lung branches in wild-type mice at 11.5 dpc. (T) Quantification of the cell proliferation rate in the epithelium of control and Wnt5a−/− lungs at 12.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). The rate of epithelial cell proliferation was calculated as the ratio of the number of EdU+ epithelial cells (EdU+E-Cad+) to the number of epithelial cells (E-Cad+). (U-B’) Ventral views of dissected lungs from control, Wnt5af/f; Sox9Cre/+ and Wnt5af/f; Dermo1Cre/+ embryos at the developmental stages indicated. (***) p < 0.001; ns, not significant. The underlying data for Fig 1J, 1K, 1L and 1T and the exact P values can be found in S1 Data. (Scale bars: A-F, 0.5 mm; G-I, 1 mm; M-R, 25 μm; U, V, Y, Z, 0.5 mm; W, X, A’, B’, 1 mm.) dpc, days post coitus; RAc, right accessory; RCd, right caudal; RCr, right cranial; RMd, right middle.
In control lungs at 11.5 dpc, the 5 main branches designated as the right cranial (RCr), right middle (RMd), right caudal (RCd), right accessory (RAc), and left (L) branch were already fully separated (Fig 1A and 1S) [21]. Branching from these 5 branches would give rise to the 5 lobes (the cranial, middle, caudal, accessory lobes of the right lung, and a single left lobe of the left lung) in adult mice. RCr emerged at a more proximal position to that of RMd and RAc, which were at a similar axial level at this stage.
In Wnt5a-deficient lungs, the distance between the RCr and RMd branches was shortened due to the abnormal appearance of RCr at the axial level of RMd/RAc at 11.5 dpc (Fig 1B and 1C). To quantify the defects of RCr/RMd in Wnt5a−/− lungs, we measured the relative position of RCr and RMd (Fig 1J). We first determined the distance between RMd and RCr (DRMd–RCr) and the distance between RMd and the bifurcation point (from the trachea) (DRMd–bifurcation), respectively, and calculated their ratio (RRCr–RMd). The relative distance (RRCr–RMd) between RCr and RMd was reduced in Wnt5a−/− lungs.
The direction of the RMd and RAc branches relative to the RCd branch was also altered at 11.5 dpc. By contrast, the direction of RCr and left L1 (L.L1) was unaltered. We measured the angle between RMd and RCd (θRMd–RCd) and the angle between RCd and RAc (θRCd–RAc) (Fig 1K and 1L). In the absence of Wnt5a, θRMd–RCd was increased in 75% and reduced in 25% of the mutant lungs. θRCd–RAc was reduced in Wnt5a−/− lungs.
In approximately 25% of Wnt5a-deficient lungs, the distance between the left L1 (L.L1) and L2 (L.L2) branches was reduced at 11.5 dpc. Moreover, we observed a complex change in the position and direction of branches derived from RCr and L.L1 in Wnt5a mutant lungs. The founder branch for RCr and L.L1 were initially produced at the correct position and orientation and bifurcated to form the longitudinal and lateral branches. At 12.5 dpc, the daughter branches of RCr and L.L1 displayed defects in the position and direction where they branched. While the lateral branch from RCr and L.L1 ramified to form the main growth axis of the cranial and left lobes in control lungs, respectively, it was the longitudinal branch of RCr and L.L1 in Wnt5a−/− lungs that dominated the main growth axis of the corresponding lobe.
Daughter branches extended from the 5 main branches and subsequent branches also exhibited defective branching (Figs 1D–1F and 1G–1I and S1). At 12.5 dpc, the overall branching pattern of Wnt5a−/− lungs had diverged significantly from that in wild-type lungs. Together, these results suggest that Wnt5a signaling controls the position and direction of early lung branching.
We noticed a shortened trachea in Wnt5a−/− lungs and wondered whether reduced cell proliferation in lung epithelial cells could be related to the branching defects. Interestingly, loss of Wnt5a did not perturb proliferation of lung epithelial cells. No difference in EdU+ epithelial cells between control and Wnt5a−/− lungs at 12.5 dpc was detected (Fig 1M–1R and 1T). This finding suggests that the primary defect in the absence of Wnt5a is likely changes in cellular organization.
Loss of Wnt5a in either the lung mesenchyme or epithelium impairs branching morphogenesis
Wnt5a is expressed in both the lung epithelium and mesenchyme. To explore how Wnt5a in different niches controls lung branching, we selectively removed Wnt5a in the lung mesenchyme with the expectation that mesenchymal Wnt5a would trigger in part epithelial PCP signaling. We produced Wnt5af/f; Dermo1Cre/+ mice in which Wnt5a was specifically eliminated in the lung mesenchyme by Dermo1-Cre [22]. Wnt5af/f; Dermo1Cre/+ mice died soon after birth. Their lungs appeared compact compared to wild-type controls at 18.5 dpc and postnatal (p) day 0. The phenotype was highly penetrant and Wnt5af/f; Dermo1Cre/+ mice exhibited branching defects. To further test this idea, we inspected Wnt5af/f; Dermo1Cre/+ lungs at different stages of lung development. We found that the early branching defects in Wnt5af/f; Dermo1Cre/+ lungs (Fig 1U–1X) were similar to those in Wnt5a−/− lungs described above.
We also tested whether Wnt5a functions in the lung epithelium to control branching. To this end, we produced Wnt5af/f; ShhCre/+ mice. Unexpectedly, these animals were fully viable and, besides a mild digit phenotype, could not be distinguished from their wild-type littermates. To exclude the possibility that Shh-Cre [23] was inefficient in deleting Wnt5a, we generated Wnt5af/f; Sox9Cre/+ mice. While Sox9-Cre [24] is activated a few days later than Shh-Cre, we suspect that Sox9-Cre could be more effective than Shh-Cre in removing Wnt5a in the lung epithelium. Branching in Wnt5af/f; Sox9Cre/+ lungs appeared normal at 11.5 dpc. Approximately 40% of Wnt5af/f; Sox9Cre/+ mice exhibited lung defects (Fig 1Y–1B’) similar to but milder than those in Wnt5a−/− lungs at 12.5 dpc. However, the branching defects in most Wnt5af/f; Sox9Cre/+ lungs were not apparent until 13.5 dpc, reflecting the onset of Sox9-Cre expression at or after 11.5 dpc. Approximately 70% of Wnt5af/f; Sox9Cre/+ mice displayed lung branching defects at 13.5 dpc, which were restricted to the lineage branches from RCr, RMd, and L.L1. Defective branching in the RCr, RMd, and L.L1 lineages did not emerge from their daughter branches, but from the subsequent secondary or tertiary branches. As a result, axis extension was only partially affected and the growth axis of the lobes was preserved.
Cell proliferation was unaltered in Wnt5af/f; Sox9Cre/+ lungs at 13.5 dpc and Wnt5af/f; Dermo1Cre/+ at 12.5 dpc (S2 Fig). Together, these results suggest that noncanonical Wnt signaling operates in both lung epithelium and mesenchyme to coordinate lung branching.
Global elimination of Vangl1/2 exhibits branching defects, similar to but milder than those due to loss of Wnt5a
To understand how the PCP pathway controls lung branching, we eliminated PCP signaling in the lung by generating mice deficient in both Vangl1 and Vangl2. To this end, we set up crosses between Vangl1gt/gt; Vangl2f/+; Sox2Cre/+ and Vangl1gt/gt; Vangl2f/f mice and collected embryos at different developmental stages (10.5 to 18.5 dpc). Vangl1gt is a gene-trapped allele [25] that leads to a complete loss of Vangl1 activity while a floxed (f) allele of Vangl2 (Vangl2f) [26] is converted into a null allele (Vangl2−) upon Cre expression. We focused on Vangl1gt/gt; Vangl2f/f; Sox2Cre/+ embryos (denoted as Vangl1gt/gt; Vangl2−/− in this study) that are deficient in both Vangl1 and Vangl2. Early ubiquitous expression of Sox2-Cre resulted in the production of Vangl2− from Vangl2f in all tissues (Fig 2A–2F). Of note, Vangl1gt/gt mice are viable and fertile without apparent phenotypes. We noticed that neither Vangl2−/− nor Vangl1gt/+; Vangl2−/− lungs displayed branching defects despite the fact that all of these embryos had an open neural tube. This is consistent with a functional redundancy between Vangl1 and Vangl2 during lung branching. Such a dose-dependent effect of Vangl1/2 levels on PCP signaling has been documented in several other tissues.
(A-F) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc. CATNB (CTNNB1) labeled epithelial and mesenchymal cells. (G-O) Ventral (G, H, J, K, M, N) and dorsal (I, L, O) views of dissected lungs from control and Vangl1gt/gt; Vangl2−/− embryos at the developmental stages indicated. (P) Quantification of the ratio of the distance of RMd–RCr to the distance of RMd–bifurcation (mean value ± SEM, unpaired Student’s t-test, n = 12 pairs). (Q) Quantification of the angle (in degrees) between RMd and RCd branches (mean value ± SEM, unpaired Student’s t-test, n = 12 pairs). (R) Quantification of the angle (in degrees) between RAc and RCd branches (mean value ± SEM, unpaired Student’s t-test, n = 12 pairs). (S-X) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc. (Y) Quantification of the cell proliferation rate in the epithelium of control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). The rate of epithelial cell proliferation was calculated as the ratio of the number of EdU+ epithelial cells (EdU+E-Cad+) to the number of epithelial cells (E-Cad+). (Z-C’) Ventral views of dissected lungs from ShhCre/+; ROSA26mTmG/+ embryos at the developmental stages indicated. Note that A’-C’ came from embryos within the same litter. Arrows point to enlarged lumen where RCr and RMd will emerge. (D’-G’) Ventral views of dissected lungs from control and Vangl1gt/gt; Vangl2−/− embryos within the same litter at approximately 11.25 dpc. Arrows point to changes in the overall shape and direction of the epithelial sheet where RCr and RMd will emerge in Vangl1gt/gt; Vangl2−/− lungs. (*) p < 0.05; (**) p < 0.01; ns, not significant. The underlying data for Fig 2P, 2Q, 2R and 2Y and the exact P values can be found in S1 Data. (Scale bars: A-F, 25 μm; G-O, 0.5 mm; S-X, 25 μm; Z-G’, 0.5 mm) dpc, days post coitus; RAc, right accessory; RCd, right caudal; RCr, right cranial; RMd, right middle.
Vangl1gt/gt; Vangl2−/− embryos exhibited an open neural tube and a shortened axis and died shortly after birth as stated in prior publications [26]. At 18.5 dpc, their lungs appeared more compact than control lungs while the lumen diameter in the airways was reduced. This suggested defects in lung branching due to loss of PCP signaling.
We examined lung branching in Vangl1gt/gt; Vangl2−/− lungs at earlier stages. The first sign of defective branching detected at 11.5 dpc was misplacement of lung buds (Fig 2G–2I), similar to those observed in Wnt5a−/− or Wnt5af/f; Dermo1Cre/+ lungs. However, subsequent branching defects in Vangl1gt/gt; Vangl2−/− lungs were not as pronounced (Figs 2J–2R and S3) as those in Wnt5a−/− or Wnt5af/f; Dermo1Cre/+ lungs. These results suggest that Vangl1/2 mediate Wnt5a signaling in controlling branching but Wnt5a has additional targets other than Vangl1/2. No difference in EdU+ epithelial cells between control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 dpc was detected (Fig 2S–2Y), again supporting a primary defect in cellular organization. No apparent defects in smooth muscle cells or blood vessels were detected in Vangl1gt/gt; Vangl2−/− lungs (S4 Fig).
To further understand how Wnt5a–Vangl1/2 signaling controls lung branching, we traced lung development in control and Vangl1/2 mutant lungs from 11.0 to 11.5 dpc. We found that the epithelium where RCr/RMd and L.L1/L.L2 emerge underwent coordinated morphological changes in control lungs (Fig 2Z–2C’). The lumen was enlarged first. Rudiments of RCr/RMd and L.L1/L.L2 were then formed. Meanwhile, the mesenchyme appeared to “push down” the epithelium between the two future branches. Finally, RCr/RMd and L.L1/L.L2 emerged at the defined position and direction. We speculate that the mechanical force between cells is affected in the absence of Wnt5a–Vangl1/2 signaling. This could alter the overall shape and orientation of the epithelial sheet. As a result, the relative position and direction of RCr/RMd and L.L1/L.L2 were affected (Fig 2D’–2G’).
Unlike Wnt5a, no apparent branching defects were observed in Vangl1gt/gt; Vangl2f/f; Sox9Cre/+ or Vangl1gt/gt; Vangl2f/f; Dermo1Cre/+ lungs (S5N–S5Q Fig). Although Sox9-Cre was expressed after early branching had initiated, epithelial Vangl2 was efficiently removed in Vangl2f/f; Sox9Cre/+ lungs by 14.5 dpc (S5A–S5M Fig) when active branching was proceeding. This suggests that coordination of Vangl1/2 signaling (hence the downstream effectors) in both the epithelium and mesenchyme contribute to lung branching.
Foxa2 participates in transducing the Wnt5a signal during lung branching
The discrepancy in phenotypes between Wnt5a and Vangl1/2 mutant lungs prompted us to search for Wnt5a targets other than Vangl1/2. We performed qPCR analysis on control and Wnt5a-deficient lungs to identify these potential targets. We found that Foxa2 expression in the lung was significantly reduced in the absence of Wnt5a at 12.5 dpc (S6 Fig).
We then tested if Wnt5a regulated Foxa2 expression through noncanonical or canonical pathways. Foxa2 expression was unaltered in Vangl1gt/gt; Vangl2−/− lungs by qPCR analysis (S6 Fig), suggesting that Foxa2 expression is not controlled by noncanonical Wnt5a signaling. Moreover, expression of β-catenin-related genes (such as Axin2 and Lef1) was reduced in Wnt5a−/− lungs (S6 Fig). These results support the notion that Wnt5a controls Foxa2 expression through the canonical pathway. Loss of Foxa1 and Foxa2 transcription factors has been reported to result in defective branching [27]. We speculate that Wnt5a coordinates lung branching by signaling through Vangl1/2, Foxa2, and other targets. The role of Foxa2 in mediating Wnt5a function in lung branching requires future investigation.
RNA-Seq and proteomic analysis reveals pathways that regulate focal adhesions, ECM–receptor interactions, and the actomyosin cytoskeleton during PCP-mediated lung branching
To uncover the molecular basis that underlies the branching defects in PCP mutant lungs, we performed RNA-Seq analysis of control, Wnt5af/f; Dermo1Cre/+, Wnt5af/f; Sox9Cre/+, and Vangl1gt/gt; Vangl2−/− lungs. Pathway analysis revealed perturbed pathways in the mutant lungs that regulate focal adhesions, extracellular matrix (ECM)–receptor interactions and the actomyosin cytoskeleton (Fig 3A–3C). These pathways were also found to be perturbed through proteomic analysis of control and Vangl1/2 knockout cells by mass spectrometry (Fig 3D). Control and Vangl1/2 knockout cells were derived from control and Vangl1gt/gt; Vangl2−/− embryonic lungs, respectively.
(A) KEGG pathway analysis of bulk RNA-Seq of control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 dpc. Bulk RNA-Seq data were deposited to Gene Expression Omnibus database (GSE188993). (B) KEGG pathway analysis of bulk RNA-Seq of control and Wnt5af/f; Sox9Cre/+ lungs at 13.5 dpc. Bulk RNA-Seq data were deposited to Gene Expression Omnibus database (GSE188993). (C) KEGG pathway analysis of bulk RNA-Seq of control and Wnt5af/f; Dermo1Cre/+ lungs at 12.5 dpc. Bulk RNA-Seq data were deposited to Gene Expression Omnibus database (GSE188993). (D) KEGG pathway analysis of the proteomes of control and Vangl1gt/gt; Vangl2−/− cells. All mass spectrometry data can be found in the S1 Table and also are publicly available via the UCSD Mass Spectrometry Interactive Virtual Environment (MassIVE), a full member of the Proteome Exchange consortium, under the dataset number MSV000089851. (E-J) Ventral views of dissected lungs from control and Vangl1gt/gt; Vangl2−/− embryos at the developmental stages indicated. E-Cad marked epithelial cells. (K) Quantification of FAK and p-FAK signal per cell in control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 4 pairs). (L-W) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc. (X-A’) Immunofluorescence of control and Vangl1gt/gt; Vangl2−/− cells. Phalloidin stained F-actin. (B’) Quantification of normal and defective p-FAK in control and Vangl1gt/gt; Vangl2−/− cells (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). (C’) Quantification of the ratio of p-FAK to FAK in control cells, Vangl1gt/gt; Vangl2−/− cells, and Vangl1gt/gt; Vangl2−/− cells expressing VANGL2 or VANGL2 (84A) (mean value ± SEM, one-way ANOVA, n = 3 pairs). (*) p < 0.05; (**) p < 0.01; (***) p < 0.001; ns, not significant. The underlying data for Fig 3K, 3B’ and 3C’ and the exact P values can be found in S1 Data. (Scale bars: E-J, 0.5 mm; L, O, R, U, 25 μm; M, N, P, Q, S, T, V, W, 5 μm; X, Y, 10 μm; Z, A’, 5 μm.) dpc, days post coitus; FAK, focal adhesion kinase; p-FAK, phosphorylated FAK.
To further test the functional role of focal adhesions in lung branching, we examined expression of focal adhesion kinase (FAK) and phosphorylated FAK (p-FAK) [28] in control and Wnt5a- or Vangl1/2-deficient lungs (Figs 3E–3W and S7 and S8). p-FAK is an indicator of the activity of focal adhesion, a mechanical link between the ECM and intracellular actin bundles. FAK and p-FAK were widely expressed in lung epithelial cells, and the signal was concentrated along the apical and basal surface (Fig 3M, 3N, 3S and 3T). VANGL2 is expressed in all lung cells and is concentrated at the apical region of epithelial cells, where VANGL2 expression colocalizes with p-FAK and the actin cytoskeleton (S5A–S5M Fig). FAK expression and distribution were unaltered in the absence of PCP signaling (Fig 3P and 3Q). By contrast, the levels of p-FAK were significantly reduced albeit the subcellular distribution of p-FAK was unaltered in the lung epithelium of mutant lungs (Fig 3V and 3W). This conclusion was confirmed by Western blot analysis of lysates from Wnt5a- or Vangl1/2-deficient lungs (S9 Fig). The protein levels of p-FAK were significantly diminished in the mutant lungs and cells. These results suggest that FAK phosphorylation after cell activation is compromised in the absence of PCP signaling. They also suggest that cell-matrix adhesions (focal adhesions) are perturbed in Wnt5a and Vangl1/2 knockout lungs. Without proper focal adhesions, lung epithelial cells would fail to undergo morphogenetic changes required to produce branches at the correct position and direction.
To better visualize focal adhesions, ECM and the actin cytoskeleton, we examined the cellular properties of control and Vangl1/2 knockout cells on fibronectin-coated dishes. After culturing for 48 h, control cells already formed a well-organized network of actin cytoskeleton, which bound to the fibronectin through FAK (Fig 3X, 3Z and 3B’). p-FAK indicated successful cell activation through interactions with fibronectin. By contrast, these characteristic features were not detected in Vangl1/2 knockout cells (Figs 3Y, 3A’ and 3B’ and S9). Introduction of the wild-type but not the mutant form of VANGL2 (VANGL2–84A) to Vangl1/2 knockout cells restored p-FAK expression (Figs 3C’ and S9). WNT5A induces phosphorylation of VANGL2 at position 84 and VANGL2–84A blocks signal transduction of WNT5A [29]. These results support a model in which a signaling cascade of Wnt5a–Vangl1/2 controls focal adhesions during specification of the position and direction of lung branches.
We noted increased levels of phosphorylated Cofilin (p-Cofilin) [30] in Vangl1/2 knockout lungs compared to controls (S10 Fig). This suggests that the assembly and disassembly of actin filaments regulated by Cofilin are affected in the mutant lungs. By contrast, the expression levels of Laminin, phosphorylated myosin light chain (pMLC) or F-actin [31] visualized by phalloidin were not significantly altered in the absence of Vangl1/2 (S11 Fig).
Perturbed focal adhesions in lung explants are associated with defective branching
To assess the functional role of focal adhesions during lung branching, we applied FAK inhibitor, PF-573228 [32], to lung explants to disrupt the function of focal adhesions (S12 Fig). After incubation with PF-573228 for 4 h, the branching direction and position of the middle lobe of lung explants was altered (Fig 4A–4L and 4Y). If lung explants were treated for 8 h, branching of most lobes was disrupted (Fig 4M–4R and 4Y). For instance, the position and direction of branches in the cranial lobe, middle lobe, and L.L1 were perturbed (Fig 4Y). E-Cad levels were reduced upon FAK inhibition (Fig 4S–4X). Together, these findings suggest that p-FAK (hence focal adhesions) is one of the many downstream effectors of Wnt5a–Vangl1/2 signaling that contribute to lung branching.
(A-R) Immunostaining of lung explants treated with control media or PF-573228 (FAK inhibitor). E-Cad marked epithelial cells. (S-X) Immunostaining of lung explants treated with control media or PF-573228. Phalloidin stained F-actin. (Y) Schematic diagram detailing the branching defects in lung explants treated with PF-573228. (Z) A model of how Wnt5a–Vangl1/2 signaling controls the cytoskeleton and focal adhesions to specify the position and direction of lung branches. PCP signaling influences the cytoskeleton/FAK/integrin/ECM complex and induces mechanical force through the coordination between the epithelium and mesenchyme. This results in reorganization of the epithelial sheet (shape and orientation) and determines the position and direction of a new branch. Consistent with this model, loss of Wnt5a or Vangl1/2 leads to incorrect positions and directions of RCr and RMd. (Scale bars: A-C, G-I, and M-O, 0.5 mm; D-F, J-L, and P-R, 0.125 mm; S-X, 25 μm.) dpc, days post coitus; ECM, extracellular matrix; FAK, focal adhesion kinase; L, left branch; PCP, planar cell polarity; RAc, right accessory; RCd, right caudal; RCr, right cranial; RMd, right middle.
Discussion
Our studies have identified a Wnt5a–Vangl1/2 axis as a key component that controls the position and direction of lung branching. In this model, cytoskeletal reorganization and changes in focal adhesions induced by Wnt5a signaling drive branching morphogenesis by establishing the position and direction of lung branches. These findings provide new mechanistic insights into lung branching morphogenesis (Fig 4Z). They will also serve as a paradigm for understanding the molecular pathways that regulate branching morphogenesis in other organs.
Our results support a model in which Wnt5a controls the position and direction of branching through Vangl1/2. However, the Wnt5a–Vangl1/2 axis likely functions in a signaling network. In this scenario, Wnt5a has additional targets and Foxa2 is not only regulated by other pathways but Foxa2 also controls other processes. We propose that Foxa2 is regulated by pathways other than Wnt5a signaling. In this regard, it is interesting to note that loss of both Foxa1 and Foxa2 disrupts branching morphogenesis, and epithelial cell proliferation and differentiation were inhibited [27]. Additional analysis is necessary to reveal the signaling network in which Wnt5a and Vangl1/2 function.
We were somewhat surprised that the branching defects in Vangl1gt/gt; Vangl2−/− lungs were less severe than those in Wnt5a−/− lungs. This finding suggests that PCP signaling is one of the several pathways employed during early lung branching to orchestrate the position and direction of lung branches. Likewise, it would be important to identify the cellular processes controlled by additional targets of Wnt5a.
The Wnt5a–Vangl1/2 axis is an essential component of the machinery involved in selecting branch points and directing branch angles. Our results suggest that the actomyosin cytoskeleton and focal adhesions are perturbed in the absence of PCP signaling. We do not have the cellular resolution to reveal how these changes modify the collective behavior of cells near the prospective branch point to form a new branch. We speculate that PCP signaling influences the cytoskeleton/FAK/integrin/ECM complex and induces mechanical force [33]. Force production through the coordination between the epithelium and mesenchyme controls the shape and orientation of the epithelial sheet and consequently determines the position and direction of a new branch (Fig 4Z). To test this model would rely on further investigation into how coordination between the lung epithelium and mesenchyme leads to mechanical force production at the cellular level. However, other cellular processes mediated by PCP signaling could also contribute to the selection of branch position and direction. Additional genetic studies are also required to identify other pathways that interact with Wnt5a–Vangl1/2 signaling to control branch position and direction. These investigations would provide insight into how cells at different locations respond differentially to Wnt5a–Vangl1/2 signaling to initiate new lung branches. In this regard, it is interesting to note that certain lung branches are preferentially affected by Wnt5a–Vangl1/2 signaling.
Wnt5a is expressed in multiple cell types in the developing lung as observed from in situ hybridization and single-cell RNA-seq. In this study, we have functionally defined the role of epithelial and mesenchymal Wnt5a in directing lung branching. However, the molecular and cellular events downstream of epithelial and mesenchymal Wnt5a signaling are unclear. Moreover, whether Wnt5a in other cell types, such as endothelial cells and pericytes, also regulates lung branching requires additional studies using genetic and molecular approaches. It is anticipated that the Wnt5a signal is received by a distinct subset of receptors/coreceptors and participates in a different signaling network in a given tissue or biological process.
Both Vangl1gt/gt; Vangl2f/f; ShhCre/+ and Vangl1gt/gt; Vangl2f/f; Sox9Cre/+ mice exhibit no branching defects although Vangl1gt/gt; Vangl2f/f; Sox9Cre/+ mice subsequently develop alveolar phenotypes [34]. Shh-Cre fails to efficiently remove Vangl2 while the late onset of Sox9-Cre expression is incapable of eliminating Vangl2 before early branching ensues. Previous studies failed to uncover phenotypes in the trachea of Wnt5af/f; ShhCre/+ mice [35]. This is consistent with our findings in which no defects in tracheal development or lung branching were observed. This was due to inefficient removal of Wnt5a by Shh-Cre and again highlights the importance of employing multiple Cre lines for conditional inactivation [34,36].
In summary, our work in this study has addressed the fundamental question of how lung branches are produced in the defined three-dimensional space. Identification of the signaling network coupled with genetic and cell biological studies will yield additional insight into this important issue.
Materials and methods
Animal husbandry
All the mouse experiments were performed following the protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the University of California, San Francisco (UCSF) (AN187712). The mouse genotypes and ages were indicated in the main text and figures. The following mouse lines were used in this study: Vangl1gt [Vangl1GT(XL802)Byg] and Vangl2f [Vangl2tm1.1Yy] were provided by Dr. Yingzi Yang [26]. Wnt5af [B6;129S-Wnt5atm1.1Krvl/J], ROSA26mTmG [Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J], Sox2-Cre [B6.Cg-Edil3Tg(Sox2-cre)1Amc/J] and Shh-Cre [B6.Cg-Shhtm1(EGFP/cre)Cjt/J] were obtained from Jackson Laboratory (Bar Harbor, ME, USA). Dermo1-Cre [Twist2tm1.1(cre)Dor/J] was obtained from Dr. David Ornitz [22]. Sox9-Cre [Sox9tm3(Cre)Crm] was obtained from Dr. Benoit de Crombrugghe [24].
Immunohistochemistry
Immunofluorescence was performed as previously described [34,37,38]. In brief, mouse embryonic lungs were collected at the indicated time points and fixed with 4% paraformaldehyde (PFA) on ice for 1 h. The samples were embedded in OCT and sectioned at 7 μm. The primary antibodies used were as follows: rat anti-E cadherin (1:200, Life Technologies, Cat# 13–1900, RRID:AB_86571), mouse anti-β-catenin (1:100, BD Transduction Laboratories, Cat# 610154, RRID:AB_397555), rat anti-PECAM1(MEC13.3) (1:100, Santa Cruz Biotechnology, Cat# sc-18916, RRID:AB_627028), rat anti-VANGL2 (1:100, MilliporeSigma, Cat# MABN750, RRID:AB_2721170), rabbit anti-FAK (1:100, Cell Signaling Technology, Cat# 3285S, RRID:AB_2269034), rabbit anti-Phospho-FAK (Tyr397) (1:100, Cell Signaling Technology, Cat# 3283S, RRID:AB_2173659), rabbit anti-Cofilin (1:150, Cell Signaling Technology, Cat# 5175S, RRID:AB_10622000), rabbit anti-phospho-Cofilin (Ser3) (1:100, Cell Signaling Technology, Cat# 3313S, RRID:AB_2080597), rabbit anti-Laminin (1:150, Sigma-Aldrich, Cat# L9393, RRID:AB_477163), rabbit anti-pMLC (S19) (1:100, Cell Signaling Technology, Cat# 3671S, RRID:AB_330248), mouse anti-ACTA2 (1:200, Thermo Scientific Lab Vision, Cat# MS-113-P0, RRID:AB_64001), and chicken anti-GFP (1:200, abcam, Cat# ab13970, RRID:AB_300798). Secondary antibodies and conjugates used were as follows: donkey anti-rabbit Alexa Fluor 488 or 594 (1:1,000, Life Technologies), donkey anti-mouse Alexa Fluor 488 or 594 (1:1,000, Life Technologies), and donkey anti-rat Alexa Fluor 594 (1:1,000, Life Technologies). The biotinylated secondary antibodies used were goat anti-hamster (1:1,000, Jackson ImmunoResearch Laboratories), donkey anti-rabbit (1:1,000, Jackson ImmunoResearch Laboratories), donkey anti-rat (1:1,000, Jackson ImmunoResearch Laboratories), and horse anti-mouse (1:1,000, Jackson ImmunoResearch Laboratories). The signal was detected using streptavidin-conjugated Alexa Fluor 488, 594, or 647 (1:1,000, Life Technologies) or HRP-conjugated streptavidin (1:1,000, Perkin-Elmer) coupled with fluorogenic substrate Alexa Fluor 594 or 488 tyramide for 30 s (1:200, TSA kit; Perkin Elmer). F-actin was stained with rhodamine-conjugated phalloidin (1:200, MilliporeSigma) in PBS for 2 h.
Confocal images were captured using a Leica SPE laser-scanning confocal microscope. Adjustment of red/green/blue/gray histograms and channel merges were performed using LAS AF Lite software (Leica Microsystems).
Whole mount immunostaining of mouse lungs
Whole mount immunostaining of embryonic lungs was performed as previously described [36]. Briefly, the whole embryonic lungs were dissected out and fixed in 4% PFA on ice for 1 h. Lungs were washed with PBS and dehydrated in graded methanols (25%, 50%, 75%, 100%). After incubating in 5% H2O2/methanol for 4 h, the samples were then rehydrated through graded methanols (100%, 75%, 50%, 25%, 0%) diluted in 0.1% Tween-20/PBS and incubated with blocking buffer (1.5% BSA/0.5% Triton X-100/PBS) for 2 h. The samples were then incubated with primary antibodies at 4°C overnight. The primary antibodies used were as follows: rat anti-E cadherin (1:200, Life Technologies, Cat# 13–1900), goat anti-SOX9 (1:100, R&D Systems, Cat# AF3075, RRID:AB_2194160), rabbit anti-FAK (1:100, Cell Signaling Technology, Cat# 3285S, RRID:AB_2269034), and rabbit anti-Phospho-FAK (Tyr397) (1:100, Cell Signaling Technology, Cat# 3283S, RRID:AB_2173659). On the second day, the samples were washed with blocking buffer for 5 h, then incubated with secondary antibodies at 4°C overnight. The final day, the samples were washed for 5 h with blocking buffer. Images were captured using a Nikon Eclipse E1000 microscope with SPOT 2.3 CCD camera.
Cell proliferation assays
The proliferation of embryonic lung cells was assessed by EdU incorporation as previously described [36]. Pregnant females at indicated time points were intraperitoneally injected with appropriate EdU/PBS solution for 1 h before collection. The Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies) was used to assess EdU incorporation. The sections were costained with the epithelial cell marker E-Cadherin (E-Cad). The proliferation rate was calculated as the ratio of (EdU+E-Cad+ cells)/(E-Cad+ cells).
RNA-seq analysis
RNA-seq was performed as previously described [34]. Briefly, the embryonic lungs from Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc, Wnt5af/f; Dermo1Cre/+ mice at 12.5 dpc and Wnt5af/f; Sox9Cre/+ at 13.5 dpc were lysed in 0.5 ml TRIzol (Life Technologies) and 100 μl chloroform was then added. After centrifugation at 4°C for 15 min, the upper aqueous layer was collected and mixed with an equal volume of 70% ethanol. RNA was extracted with the RNeasy Mini Kit (Qiagen) following the manufacturer’s instructions. RNA quality was evaluated using an Agilent 2100 Bioanalyzer. Samples were sequenced on an Illumina HiSeq 2000 or HiSeq4000. Differential gene expression, gene ontology (GO) enrichment analyses, and the barplot of gene ontology enrichment were performed using RStudio. Datasets have been deposited in NCBI’s Gene Expression Omnibus database and are accessible through GEO Series accession number (GSE188993).
Mass spectrometry data acquisition and analysis
Sample preparation.
Cell pellets were thawed on ice and subjected to sample preparation with the PreOmics iST kit (PreOmics, Planegg, Germany) according to the manufacturer’s protocol. Samples were resuspended in LC-Load Buffer from the iST kit and peptide concentration determined (Pierce Quantitative Colorimetric or Fluorescent Peptide Assay, ThermoFisher Scientific, Waltham, Massachusetts). Sample concentration was normalized to 100 ng/μl and 2 μl was loaded onto the instrument.
Mass spectrometry analysis—Liquid chromatography and timsTOF Pro.
A nanoElute was attached in line to a timsTOF Pro equipped with a CaptiveSpray Source (Bruker, Hamburg, Germany). Chromatography was conducted at 40°C through a 25-cm reversed phase C18 column (PepSep) at a constant flow rate of 0.5 μl/min. Mobile phase A was 98/2/0.1% Water/MeCN/Formic Acid (v/v/v) and phase B was MeCN with 0.1% Formic Acid (v/v). During a 108-min method, peptides were separated by a 3-step linear gradient (5% to 30% B over 90 min, 30% to 35% B over 10 min, 35% to 95% B over 4 min) followed by a 4-min isocratic flush at 95% for 4 min before washing and a return to low organic conditions. Experiments were run as data-dependent acquisitions with ion mobility activated in PASEF mode. MS and MS/MS spectra were collected with m/z 100 to 1,700 and ions with z = +1 were excluded.
Raw data files were searched using PEAKS Online Xpro 1.6 (Bioinformatics Solutions, Waterloo, Ontario, Canada). The precursor mass error tolerance and fragment mass error tolerance were set to 20 PPM and 0.02, respectively. The trypsin/Lys-C digest mode was set to semispecific and missed cleavages were set to 2. The human Swiss-Prot reviewed (canonical) database (downloaded from UniProt) and the common repository of adventitious proteins (cRAP, downloaded from The Global Proteome Machine Organization) totaling 20,487 entries were used. Carbamidomethylation was selected as a fixed modification. Deamidation (NQ) and Oxidation (M) were selected as variable modifications. A maximum of 3 variable modifications were allowed.
All experiments were repeated in biological triplicate and technical duplicate and subjected to the following filtration criteria:
- During the PEAKS Online Xpro export process, a false discovery rate (FDR) cutoff for peptide identification was applied, and only peptides with FDR ≤1% were included.
- Proteins were groups were required to have a FDR ≤1%.
All mass spectrometry data can be found in the S1 Table and also are publicly available via the UCSD Mass Spectrometry Interactive Virtual Environment (MassIVE), a full member of the Proteome Exchange consortium, under the dataset number MSV000089851.
qPCR analysis
The qPCR assay was performed as previously described [34]. RNAs were extracted with the RNeasy Mini Kit (Qiagen) following the manufacturer’s instructions. The extracted RNAs were reverse-transcribed with the Maxima First Strand cDNA Synthesis Kit (Thermo Scientific). Quantitative PCR (qPCR) was performed on an Applied Biosystems QuantStudio 5 Real-Time PCR System. Primers for qPCR are as follows:
mouse Foxa2 forward, 5′-CATGGGACCTCACCTGAGTC-3′; reverse, 5′-CATCGAGTTCATGTTGGCGTA-3′, mouse Axin2 forward, 5′-ATGGAGTCCCTCCTTACCGCAT-3′; reverse, 5′-GTTCCACAGGCGTCATCTCCTT-3′, mouse Lef1 forward, 5′-ACTGTCAGGCGACACTTCCATG-3′; reverse, 5′-GTGCTCCTGTTTGACCTGAGGT-3′, mouse Mmp9 forward, 5′-GACATAGACGGCATCCAGTATC-3′; reverse, 5′-GGTATAGTGGGACACATAGTGG-3′, mouse Bmp4 forward, 5′-CGAGCCAACACTGTGAGG-3′; reverse, 5′-GAAGAGGAAACGAAAAGCAGAG-3′, mouse Vegfa forward, 5′-GGCAAAGTGACTGACCTGCT-3′; reverse, 5′-CTGTCTGTCTGTCCGTCAGC-3′, mouse Gapdh forward, 5′-AGGTTGTCTCCTGCGACTTCA-3′; reverse, 5′-CCAGGAAATGAGCTTGACAAAGTT-3′.
Derivation and culture of primary lung cells
Control and Vangl1gt/gt; Vangl2−/− embryos at 12.5 dpc were dissected, and the lungs were digested in 0.1% trypsin–EDTA at 37°C for 20 min. The cells were then incubated in DMEM containing 10% FBS, 1× penicillin/streptomycin and 1× L-glutamine.
Lentiviral production and transduction
3xFLAG-Vangl2 and 3xFLAG-Vangl2-84A (a gift from Dr. Yingzi Yang) [29] were cloned into the modified pSECC lentiviral vector (the eEF1a promoter replaces the cassette of [gRNA site–FLAG-SV40NLS–Cas9–NLS–P2A–Cre]).
Lentiviruses were produced as previously described [34]. HEK293T cells were plated at 60% confluence in 10-cm dishes 24 h before transfection. For transfection, 2 μg of pMD2.G, 2 μg of psPAX2, and 5 μg of the lentiviral plasmid (3xFLAG-Vangl2 or 3xFLAG-Vangl2-84A) were mixed in 1000 μl OPTI-MEM with 50 μl of polyethylenimine (PEI) (1 mg/ml) and added to HEK293T cells when they reached 80% to 90% confluence. Approximately 48 h post-transfection, the viral supernatants were collected, filtered through 0.45-μm PVDF membrane filters, then added to control and Vangl1gt/gt; Vangl2−/−-adherent lung primary cells together with 8 μg/ml polybrene. Media were replaced 12 h post-transduction.
Co-immunoprecipitation
The co-immunoprecipitation assay was performed as previously described [39]. Vangl1/2 knockout cell lines that stably express 3xFLAG-Vangl2 or 3xFLAG-Vangl2-84A were seeded onto 10 cm dishes until they reached 100% confluence. Cells were lysed in immunoprecipitation buffer (1% Triton X-100, 150 mM NaCl, 50 mM Tris-Cl at pH 7.5, 1 mM EDTA, protease inhibitor cocktail). The samples were centrifuged at 12,000 rpm for 15 min at 4°C. The supernatants were removed and bound to 20 μl of anti-FLAG M2 beads (Sigma) overnight at 4°C with nutating. Beads were washed 3 times with immunoprecipitation buffer and eluted with SDS sample buffer, then analyzed by Western blotting.
Western blotting analysis
Embryonic lung tissues were pipetted in RIPA buffer with 1× protease inhibitor cocktail and 1× PMSF. The lysates were centrifuged at 13,200 rpm at 4°C for 15 min, then analyzed by Western blot as previously described [34]. The primary antibodies used were as follows: mouse anti-FLAG M2 (1:3,000, MilliporeSigma, Cat# F3165, RRID:AB_259529), rabbit anti-FAK (1:1,000, Cell Signaling Technology, Cat# 3285S, RRID:AB_2269034), rabbit anti-p-FAK (Tyr397) (1:1,000, Cell Signaling Technology, Cat# 3283S, RRID:AB_2173659), and mouse anti-alpha-tubulin (1:3,000, Developmental Studies Hybridoma Bank, Cat# 12G10, RRID:AB_1157911).
Culture of mouse embryonic lungs
Culture of mouse embryonic lungs was performed as previously described [36]. Briefly, embryonic lungs were dissected from wild-type mice at 11.5 dpc and placed on top of the polycarbonate nuclepore membranes (Millipore), which were floating in cultured medium (DMEM/F-12 supplemented with penicillin/streptomycin, L-glutamine and 1% FBS) with or without the FAK inhibitor, PF-573228 (Selleck Chemicals) (2 μM in DMSO) for 4 h or 8 h. A 24-well plate that contained the samples was replaced with fresh media and then cultured for another 48 h. The lungs were then collected for RNA-Seq or for imaging.
Statistical analysis
All the biological repeats we performed were more than or equal to 3, and the detailed biological replicates (n numbers) were indicated in the figure legends. All the statistical comparisons between different groups were shown as mean value ± SEM. Two-tailed Student’s t-tests and one-way ANOVA were applied to calculate the P values and the statistical significance was evaluated as * P < 0.05, ** P < 0.01, and *** P < 0.001.
Supporting information
S1 Fig. Loss of Wnt5a leads to defective branching morphogenesis.
Ventral (A, B, D, E) and dorsal (C) views of dissected lungs from wild-type and Wnt5a−/− embryos at the developmental stages indicated. Ventral (F, G, I, J) and dorsal (H) views of dissected lungs from wild-type and Wnt5af/f; Sox9Cre/+ embryos at the developmental stages indicated. Ventral (K, L, N, O) and dorsal (M) views of dissected lungs from wild-type and Wnt5af/f; Dermo1Cre/+ embryos at the developmental stages indicated. (Scale bars: A-C, F-H, and K-M, 1 mm; D, E, I, J, N, and O, 1 mm.) dpc, days post coitus.
https://doi.org/10.1371/journal.pbio.3001759.s001
(PDF)
S2 Fig. The rate of cell proliferation is unaltered in the absence of Wnt5a.
(A-F) Immunostaining of lung sections collected from control and Wnt5af/f; Sox9Cre/+ mice at 13.5 dpc. (G) Quantification of the cell proliferation rate in the epithelium of control and Wnt5af/f; Sox9Cre/+ lungs at 13.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). The rate of epithelial cell proliferation was calculated as the ratio of the number of EdU+ epithelial cells (EdU+E-Cad+) to the number of epithelial cells (E-Cad+). (H-M) Immunostaining of lung sections collected from control and Wnt5af/f; Dermo1Cre/+ mice at 12.5 dpc. (N) Quantification of the cell proliferation rate in the epithelium of control and Wnt5af/f; Dermo1Cre/+ lungs at 12.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). The underlying data for S2G and S2N Fig and the exact P values can be found in S1 Data. (Scale bars: A-F and H-M, 25 μm.) dpc, days post coitus; ns, not significant.
https://doi.org/10.1371/journal.pbio.3001759.s002
(PDF)
S3 Fig. Vangl1/2 control the position and direction of lung branching.
Ventral (A, B, D, E, G, H) and dorsal (C, F, I) views of dissected lungs from wild-type and Vangl1gt/gt; Vangl2−/− embryos at the developmental stages indicated. (Scale bars: A-C, 0.5 mm; D-F, 1 mm; G-I, 1 mm.)
https://doi.org/10.1371/journal.pbio.3001759.s003
(PDF)
S4 Fig. Smooth muscle cells and blood vessels are unaffected in Vangl1/2 mutant lungs.
(A-D) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 15.5 dpc. SMA marks smooth muscle cells; CD31 labels endothelial cells. (Scale bar: A-D, 25 μm.) dpc, days post coitus.
https://doi.org/10.1371/journal.pbio.3001759.s004
(PDF)
S5 Fig. Selective loss of Vangl1/2 in the lung epithelium or mesenchyme does not lead to branching defects.
(A-F) Immunostaining of lung sections collected from control and Wnt5a−/− mice at 12.5 dpc. (G) Quantification of VANGL2 signal in lung cells of control or Wnt5a mutant lungs (mean value ± SEM, unpaired Student’s t-test, n = 4 pairs). (H-M) Immunostaining of lung sections collected from control and Vangl2f/f; Sox9Cre/+ lungs at 14.5 dpc. (N-Q) Ventral views of dissected lungs from control and mutant lungs at 14.5 dpc. The underlying data for S5G Fig and the exact P value can be found in S1 Data. (Scale bar: A-F, H-M, 25 μm; N-Q, 1 mm) dpc, days post coitus; ns, not significant.
https://doi.org/10.1371/journal.pbio.3001759.s005
(PDF)
S6 Fig. The transcription factor, Foxa2, and major signaling pathways in the developing lungs are perturbed in the absence of Wnt5a.
(A) qPCR analysis of Foxa2 transcript levels in control and Wnt5a−/− lungs at 12.5 and 13.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). (B) qPCR analysis of Foxa2 transcript levels in control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 and 13.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). (C) qPCR analysis of components of the major signaling pathways in control and Wnt5a−/− lungs at 12.5 dpc (mean value ± SEM, unpaired Student’s t-test, n = 3 pairs). (*) p < 0.05; (**) p < 0.01. The underlying data for S5A–S5C Fig and the exact P values can be found in S1 Data. dpc, days post coitus; ns, not significant.
https://doi.org/10.1371/journal.pbio.3001759.s006
(PDF)
S7 Fig. p-FAK is reduced in Wnt5a-null lungs.
(A-L) Whole-mount immunostaining of dissected lungs from control and Wnt5a−/− mice at 12.5 dpc. Lung epithelium was visualized by E-cadherin (E-Cad). Circles in (H, K) indicate defective branching in Wnt5a-deficient lungs. (M-T) Immunostaining of lung sections collected from control and Wnt5a−/− mice at 12.5 dpc. (Scale bars: A-L, 0.5 mm; M-T, 25 μm.) dpc, days post coitus; p-FAK, phosphorylated FAK.
https://doi.org/10.1371/journal.pbio.3001759.s007
(PDF)
S8 Fig. p-FAK is reduced in Wnt5a-deficient lung compartments.
(A-L) Immunostaining of lung sections collected from control and Wnt5af/f; Sox9Cre/+ lungs at 13.5 dpc. Lung epithelium was visualized by E-cadherin (E-Cad). (M-X) Immunostaining of lung sections collected from control and Wnt5af/f; Dermo1Cre/+ lungs at 12.5 dpc. (Scale bar: A-X, 25 μm.) dpc, days post coitus; p-FAK, phosphorylated FAK.
https://doi.org/10.1371/journal.pbio.3001759.s008
(PDF)
S9 Fig. p-FAK is reduced in the absence of Wnt5a or Vangl1/2.
(A) Western blot analysis of cell lysates derived from control and Wnt5a−/− lungs at 12.5 dpc. (B) Western blot analysis of cell lysates derived from control and Vangl1gt/gt; Vangl2−/− lungs at 12.5 dpc. (C) Western blot analysis of cell lysates derived from control cells, Vangl1gt/gt; Vangl2−/− cells and Vangl1gt/gt; Vangl2−/− cells expressing VANGL2 or VANGL2 (84A) as indicated. α-tubulin serves as the loading control. dpc, days post coitus; FAK, focal adhesion kinase; p-FAK, phosphorylated FAK.
https://doi.org/10.1371/journal.pbio.3001759.s009
(PDF)
S10 Fig. p-Cofilin levels are increased in the absence of Vangl1/2.
(A-L) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc. Lung epithelium was marked by E-cadherin (E-Cad). (M) Quantification of the relative density of Cofilin and p-Cofilin in lung cells at the epithelial tip or in the mesenchyme (mean value ± SEM, unpaired Student’s t-test, n = 4 pairs). (**) p < 0.01. The underlying data for S10M Fig and the exact P values can be found in S1 Data. (Scale bar: A-L, 25 μm.) dpc, days post coitus; ns, not significant; p-Cofilin, phosphorylated Cofilin;
https://doi.org/10.1371/journal.pbio.3001759.s010
(PDF)
S11 Fig. Expression level of Laminin, F-actin, pMLC are unaltered in Vangl1/2 mutant lungs.
(A-X) Immunostaining of lung sections collected from control and Vangl1gt/gt; Vangl2−/− mice at 12.5 dpc. Lung epithelium was marked by E-cadherin (E-Cad). F-actin was labeled by phalloidin. (Y) Quantification of phalloidin signal in lung cells of control or Vangl1/2 mutant lungs (mean value ± SEM, unpaired Student’s t-test, n = 4 pairs). (Z) Quantification of pMLC signal in lung cells of control or Vangl1/2 mutant lungs (mean value ± SEM, unpaired Student’s t-test, n = 4 pairs). The underlying data for S11Y and S11Z Fig and the exact P values can be found in S1 Data. (Scale bar: A-X, 25 μm.) dpc, days post coitus; ns, not significant; pMLC, phosphorylated myosin light chain.
https://doi.org/10.1371/journal.pbio.3001759.s011
(PDF)
S12 Fig. p-FAK is reduced in the presence of FAK inhibitor.
(A-X) Immunostaining of lung explants treated with control media or media containing 0.5 μM or 2 μM of PF-573228 (FAK inhibitor) as indicated. (Y) Quantification of the relative density of FAK and p-FAK in lung cells treated with PF-573228 (mean value ± SEM, one-way ANOVA, n = 5 pairs). (*) p < 0.05; (**) p < 0.01; (***) p < 0.001. The underlying data for S12Y Fig can be found in S1 Data. (Scale bar: A-X, 25 μm.) FAK, focal adhesion kinase; ns, not significant; p-FAK, phosphorylated FAK.
https://doi.org/10.1371/journal.pbio.3001759.s012
(PDF)
References
- 1. Hannezo E, Scheele C, Moad M, Drogo N, Heer R, Sampogna RV, et al. A Unifying Theory of Branching Morphogenesis. Cell. 2017;171(1):242–55 e27. Epub 2017/09/25. pmid:28938116; PubMed Central PMCID: PMC5610190.
- 2. Kourouklis AP, Nelson CM. Modeling branching morphogenesis using materials with programmable mechanical instabilities. Curr Opin Biomed Eng. 2018;6:66–73. Epub 2018/10/23. pmid:30345410; PubMed Central PMCID: PMC6193561.
- 3. Herriges M, Morrisey EE. Lung development: orchestrating the generation and regeneration of a complex organ. Development. 2014;141(3):502–13. Epub 2014/01/23. pmid:24449833; PubMed Central PMCID: PMC3899811.
- 4. Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell. 2010;18(1):8–23. Epub 2010/02/16. S1534-5807(09)00527-9 [pii] pmid:20152174.
- 5. Jones MR, Chong L, Bellusci S. Fgf10/Fgfr2b Signaling Orchestrates the Symphony of Molecular, Cellular, and Physical Processes Required for Harmonious Airway Branching Morphogenesis. Front Cell Dev Biol. 2020;8:620667. Epub 2021/01/30. pmid:33511132; PubMed Central PMCID: PMC7835514.
- 6. Varner VD, Nelson CM. Cellular and physical mechanisms of branching morphogenesis. Development. 2014;141(14):2750–9. Epub 2014/07/10. pmid:25005470; PubMed Central PMCID: PMC4197615.
- 7. Lang C, Conrad L, Iber D. Organ-Specific Branching Morphogenesis. Front Cell Dev Biol. 2021;9:671402. Epub 2021/06/22. pmid:34150767; PubMed Central PMCID: PMC8212048.
- 8. Humphries AC, Mlodzik M. From instruction to output: Wnt/PCP signaling in development and cancer. Curr Opin Cell Biol. 2018;51:110–116. pmid:29289896; PubMed Central PMCID: PMC5949250
- 9. Butler MT, Wallingford JB. Planar cell polarity in development and disease. Nat Rev Mol Cell Biol. 2017;18(6):375–388. pmid:28293032.
- 10. Carroll TJ, Yu J. The kidney and planar cell polarity. Curr Top Dev Biol. 2012;101:185–212. Epub 2012/11/13. pmid:23140630; PubMed Central PMCID: PMC4745260.
- 11. Blair S, McNeill H. Big roles for Fat cadherins. Curr Opin Cell Biol. 2018;51:73–80. pmid:29258012; PubMed Central PMCID: PMC5949260
- 12. Li C, Bellusci S, Borok Z, Minoo P. Non-canonical WNT signalling in the lung. J Biochem. 2015;158 (5):355–365. pmid:26261051; PubMed Central PMCID: PMC4751232
- 13. van Amerongen R, Fuerer C, Mizutani M, Nusse R. Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development. Dev Biol. 2012;369(1):101–14. Epub 2012/07/10. pmid:22771246; PubMed Central PMCID: PMC3435145.
- 14. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006;4(4):e115. Epub 2006/04/11. pmid:16602827; PubMed Central PMCID: PMC1420652.
- 15. Li C, Xiao J, Hormi K, Borok Z, Minoo P. Wnt5a participates in distal lung morphogenesis. Dev Biol. 2002;248 (1):68–81. pmid:12142021.
- 16. Murdoch JN, Doudney K, Paternotte C, Copp AJ, Stanier P. Severe neural tube defects in the loop-tail mouse result from mutation of Lpp1, a novel gene involved in floor plate specification. Hum Mol Genet. 2001;10 (22):2593–2601. pmid:11709546.
- 17. Bailly E, Walton A, Borg JP. The planar cell polarity Vangl2 protein: From genetics to cellular and molecular functions. Semin Cell Dev Biol. 2018;81:62–70. pmid:29111415.
- 18. Yates LL, Schnatwinkel C, Murdoch JN, Bogani D, Formstone CJ, Townsend S, et al. The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. Hum Mol Genet. 2010;19 (11):2251–2267. pmid:20223754; PubMed Central PMCID: PMC2865378
- 19. Ryu YK, Collins SE, Ho HY, Zhao H, Kuruvilla R. An autocrine Wnt5a-Ror signaling loop mediates sympathetic target innervation. Dev Biol. 2013;377 (1):79–89. pmid:23454479; PubMed Central PMCID: PMC3774606
- 20. Hayashi S, Lewis P, Pevny L, McMahon AP. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech Dev. 2002;119 Suppl 1:S97–S101. Epub 2003/10/01. pmid:14516668.
- 21. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature. 2008;453(7196):745–50. Epub 2008/05/09. pmid:18463632; PubMed Central PMCID: PMC2892995.
- 22. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development. 2003;130(13):3063–74. Epub 2003/05/21. pmid:12756187.
- 23. Harfe BD, Scherz PJ, Nissim S, Tian H, McMahon AP, Tabin CJ. Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell. 2004;118(4):517–28. Epub 2004/08/19. pmid:15315763.
- 24. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A. 2005;102(41):14665–70. Epub 2005/10/06. pmid:16203988; PubMed Central PMCID: PMC1239942.
- 25. Torban E, Patenaude AM, Leclerc S, Rakowiecki S, Gauthier S, Andelfinger G, et al. Genetic interaction between members of the Vangl family causes neural tube defects in mice. Proc Natl Acad Sci U S A. 2008;105 (9):3449–3454. pmid:18296642; PubMed Central PMCID: PMC2265143
- 26. Song H, Hu J, Chen W, Elliott G, Andre P, Gao B, et al. Planar cell polarity breaks bilateral symmetry by controlling ciliary positioning. Nature. 2010;466 (7304):378–382. pmid:20562861; PubMed Central PMCID: PMC3065171
- 27. Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang SL, et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem. 2005;280(14):13809–16. Epub 2005/01/26. pmid:15668254.
- 28. Hall JE, Fu W, Schaller MD. Focal adhesion kinase: exploring Fak structure to gain insight into function. Int Rev Cell Mol Biol. 2011;(288):185–225. Epub 2011/04/13. pmid:21482413.
- 29. Gao B, Song H, Bishop K, Elliot G, Garrett L, English MA, et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell. 2011;20(2):163–76. Epub 2011/02/15. pmid:21316585; PubMed Central PMCID: PMC3062198.
- 30. Ohashi K. Roles of cofilin in development and its mechanisms of regulation. Develop Growth Differ. 2015;57(4):275–90. Epub 2015/04/14. pmid:25864508.
- 31. Svitkina T. The Actin Cytoskeleton and Actin-Based Motility. Cold Spring Harb Perspect Biol. 2018;10(1). Epub 2018/01/04. pmid:29295889; PubMed Central PMCID: PMC5749151.
- 32. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem. 2007;282(20):14845–52. Epub 2007/03/31. pmid:17395594.
- 33. Martino F, Perestrelo AR, Vinarsky V, Pagliari S, Forte G. Cellular Mechanotransduction: From Tension to Function. Front Physiol. 2018;9:824. Epub 2018/07/22. pmid:30026699; PubMed Central PMCID: PMC6041413.
- 34. Zhang K, Yao E, Lin C, Chou YT, Wong J, Li J, et al. A mammalian Wnt5a-Ror2-Vangl2 axis controls the cytoskeleton and confers cellular properties required for alveologenesis. Elife. 2020;9. Epub 2020/05/13. pmid:32394892; PubMed Central PMCID: PMC7217702.
- 35. Kishimoto K, Tamura M, Nishita M, Minami Y, Yamaoka A, Abe T, et al. Synchronized mesenchymal cell polarization and differentiation shape the formation of the murine trachea and esophagus. Nat Commun. 2018;9 (1):2816. pmid:30026494; PubMed Central PMCID: PMC6053463
- 36. Lin C, Yao E, Zhang K, Jiang X, Croll S, Thompson-Peer K, et al. YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis. Elife. 2017;6. pmid:28323616; PubMed Central PMCID: PMC5360446.
- 37. Zhang K, Yao E, Chen B, Chuang E, Wong J, Seed RI, et al. Acquisition of cellular properties during alveolar formation requires differential activity and distribution of mitochondria. Elife. 2022;11. Epub 2022/04/07. pmid:35384838.
- 38. Zhang K, Yao E, Wang SA, Chuang E, Wong J, Minichiello L, et al. A functional circuit formed by the autonomic nerves and myofibroblasts controls mammalian alveolar formation for gas exchange. Dev Cell. 2022. Epub 2022/06/18. pmid:35714603.
- 39. Lin C, Yao E, Wang K, Nozawa Y, Shimizu H, Johnson JR, et al. Regulation of Sufu activity by p66beta and Mycbp provides new insight into vertebrate Hedgehog signaling. Genes Dev. 2014;28(22):2547–63. Epub 2014/11/19. pmid:25403183; PubMed Central PMCID: PMC4233246.